Home › Funds › First Turn Management, LLC › ASND

First Turn Management, LLC position in ASND

ASCENDIS PHARMA A/S · Health Care

First Turn Management, LLC reported holding 104,877 shares of ASND (ASCENDIS PHARMA A/S) in its Q2 2026 13F filing — a position valued at US$28.0M, representing 2.99% of its reported portfolio and ranking #14 among its reported holdings. First Turn Management, LLC has disclosed ASND holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)104.88K sh
Reported value held$27.97M
Portfolio Weight2.99%
First reportedQ4 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How First Turn Management, LLC's ASND position evolved

First Turn Management, LLC first disclosed a stake in ASND in Q4 2023 at 151,587 shares (US$19.1M). The position peaked in Q3 2025 at 146,291 shares, worth US$29.1M. Across 11 filings, First Turn Management, LLC increased the stake 5 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 104,877 shares valued at US$28.0M — an increase of 28,577 shares quarter over quarter.. Notable position changes include a 42% trim in Q4 2024 (shares rose 13% over the following quarter), a 42% trim in Q1 2026 (shares rose 17% over the following quarter), a 37% increase in Q2 2026 (shares fell 15% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 151.59K $19.09M New
Q1 2024 151.59K $22.92M Hold
Q2 2024 186.58K $25.45M Add
Q3 2024 150.59K $22.49M Reduce
Q4 2024 87.80K $12.09M Reduce
Q1 2025 113.28K $17.66M Add
Q2 2025 134.69K $23.25M Add
Q3 2025 146.29K $29.08M Add
Q4 2025 131.81K $28.11M Reduce
Q1 2026 76.30K $17.45M Reduce
Q2 2026 104.88K $27.97M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ASND and 13F data

ASND (ASCENDIS PHARMA A/S) is a Health Care company. 43 other funds we track also report a position in ASND — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$2.74B), T. Rowe Price Investment Management, Inc. (US$1.80B), Avoro Capital Advisors LLC (US$1.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ASND

All ASND fund holders →

FAQ

How long has First Turn Management, LLC held ASND?

First Turn Management, LLC has disclosed ASND holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

What is First Turn Management, LLC's current position in ASND?

As of Q2 2026, First Turn Management, LLC holds 104.88K shares of ASND (ASCENDIS PHARMA A/S), valued at $27.97M, representing 2.99% of its reported portfolio and ranking #14.

Has First Turn Management, LLC been buying or selling ASND?

In the latest 13F filing (Q2 2026), First Turn Management, LLC increased its position in ASND. The position peaked in Q3 2025 at 146.29K shares.

Which other funds hold ASND?

Other major institutional holders of ASND include RA CAPITAL MANAGEMENT, L.P., T. Rowe Price Investment Management, Inc., Avoro Capital Advisors LLC, among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.